Quarterlytics / Healthcare / Biotechnology / Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc.

kzr · ASX Healthcare
Claim this profile
Ticker kzr
Exchange ASX
Sector Healthcare
Industry Biotechnology
Employees 1-10
← All annual reports
FY2017 Annual Report · Kezar Life Sciences, Inc.
Sign in to download
Loading PDF…
20 September 2017 

Company Announcements Office 
Australian Securities Exchange 
Level 40, Central Park 
152-158 St Georges Terrace 
PERTH WA 6000 

ADDENDUM TO 2017 ANNUAL REPORT – ADDITIONAL INFORMATION 

In  accordance  with  ASX  Listing  Rule  4.10.19,  the  Company  advises  that  it  has  used  the 
cash  and  assets  in  a  form  readily  convertible  to  cash  that  it  had  at  the  time  of  the 
Company’s  admission  to  the  Official  List  of  ASX  Limited  on  12  January  2017  in  a  way 
consistent with its business objectives during the period from admission to 30 June 2017. 

Yours faithfully 

Bernard Crawford  
Company Secretary